A placebo-controlled, crossover comparison of oral triazolam prior to sham patient-activated shock delivery during sinus rhythm in a group of patients with recurrent atrial fibrillation.
Mitchell
Andrew R J
AR
D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000503:physiopathology; D018849:Controlled Clinical Trials as Topic / Q000379:methods; D018592:Cross-Over Studies; D004554:Electric Countershock / Q000379:methods*; D006801:Humans; D012008:Recurrence; D013997:Time Factors; D014229:Triazolam / Q000627:therapeutic use*
D014229:Triazolam